Table 1. Characteristics of the study population according to being alive or death after hospitalization for COVID-19.
| Characteristics | Overall | Alive | Death |
|---|---|---|---|
| 445 (100%) | 357 (80.2%) | 88 (19.8%) | |
| Male biological sex, n (%) | 289 (64.9) | 229 (64.1) | 60 (68.2) |
| Age, years | |||
| median (IQR) | 65 (55–75) | 63 (54–72) | 75 (68–82) |
| >75 years, n (%) | 120 (27) | 72 (20) | 48 (54) |
| CCI, median (IQR) | 2.5 (1–4) | 2 (1–4) | 4 (3–6) |
| SARS-CoV-2 pandemic wave, n (%) | |||
| 1 | 58 (13) | 47 (13.2) | 11 (12.5) |
| 2 | 21 (4.7) | 15 (4.2) | 6 (6.8) |
| 3 | 255 (57.3) | 200 (56) | 55 (62.5) |
| 4 | 111 (24.9) | 95 (26.6) | 16 (18.2) |
| Days from symptoms onset to Hospital admission, median (IQR) | 8 (5–11) | 8 (5–11) | 7 (4–10) |
| Disease severity at hospital admission, n (%) | |||
| Mild/moderate | 182 (40.9) | 156 (43.7) | 26 (29.5) |
| Severe/critical | 263 (59.1) | 201 (56.3) | 62 (70.5) |
| Doses of COVID-19 Vaccine, n (%) | |||
| 0 | 370 (83.1) | 297 (83.2) | 73 (83) |
| 1 | 37 (8.3) | 21 (5.9) | 5 (5.7) |
| 2 | 29 (6.5) | 32 (9) | 8 (9.1) |
| 3 | 9 (2) | 7 (2) | 2 (2.3) |
| Positive SARS-CoV-2 viremia at admission, n (%) | 134 (30.1) | 81 (22.7) | 53 (60.2) |
List of abbreviations: n, number; IQR, Inter Quartile Range; CCI, Charlson comorbidity index.